Your browser doesn't support javascript.
loading
Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.
Swadling, Leo; Halliday, John; Kelly, Christabel; Brown, Anthony; Capone, Stefania; Ansari, M Azim; Bonsall, David; Richardson, Rachel; Hartnell, Felicity; Collier, Jane; Ammendola, Virginia; Del Sorbo, Mariarosaria; Von Delft, Annette; Traboni, Cinzia; Hill, Adrian V S; Colloca, Stefano; Nicosia, Alfredo; Cortese, Riccardo; Klenerman, Paul; Folgori, Antonella; Barnes, Eleanor.
Afiliação
  • Swadling L; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. leo.swadling@ndm.ox.ac.uk.
  • Halliday J; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. johnshalliday@gmail.com.
  • Kelly C; Oxford NIHR BRC, and Translational Gastroenterology Unit, Oxford OX3 9DU, UK. johnshalliday@gmail.com.
  • Brown A; Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. johnshalliday@gmail.com.
  • Capone S; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. christabel_k@hotmail.com.
  • Ansari MA; Oxford NIHR BRC, and Translational Gastroenterology Unit, Oxford OX3 9DU, UK. christabel_k@hotmail.com.
  • Bonsall D; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. anthony.brown@ndm.ox.ac.uk.
  • Richardson R; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. Stefania.Capone@reithera.com.
  • Hartnell F; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. ansari.azim@gmail.com.
  • Collier J; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. david.bonsall@ndm.ox.ac.uk.
  • Ammendola V; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. r.richardson@ucl.ac.uk.
  • Del Sorbo M; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. felicity.hartnell@worc.ox.ac.uk.
  • Von Delft A; Oxford NIHR BRC, and Translational Gastroenterology Unit, Oxford OX3 9DU, UK. jane.collier@msd.ox.ac.uk.
  • Traboni C; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. Virginia.Ammendola@reithera.com.
  • Hill AV; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. Virginia.Ammendola@reithera.com.
  • Colloca S; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. annette.vondelft@chch.ox.ac.uk.
  • Nicosia A; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. Cinzia.Traboni@reithera.com.
  • Cortese R; Nuffield Department of Medicine, University of Oxford, Oxford OX1 3SY, UK. adrian.hill@ndm.ox.ac.uk.
  • Klenerman P; The Jenner Institute, University of Oxford, Oxford, OX3 7DQ, UK. adrian.hill@ndm.ox.ac.uk.
  • Folgori A; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. Stefano.Colloca@reithera.com.
  • Barnes E; Reithera Srl (former Okairos Srl), Viale Città d'Europa, 679, Rome 00144, Italy. alfredo.nicosia@reithera.com.
Vaccines (Basel) ; 4(3)2016 Aug 02.
Article em En | MEDLINE | ID: mdl-27490575
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido